tenk.fyi

Acumen Pharmaceuticals, Inc.

ABOSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$121.3M

18.6% YoY

EPS

$-2.00

17.0% YoY

Cash

$54.0M

51.5% YoY

FY 2025 · As of 2025-12-31